Largest pharmaceuticals by total liabilities
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
AbbVie leads the 61 pharmaceuticals ranked by total liabilities, at TRY 6.92T, ahead of Pfizer (TRY 6.12T) and Johnson & Johnson (TRY 5.93T). Figures as of 18 Nov 2026, 14:03 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- AbbVieTRY 6.92T
- Median
- TRY 105.1B
- Combined market value
- TRY 260.17T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Total liabilities ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AbbVieABBV · Health Care | TRY 6.92T | TRY 26.11T | TRY 14,769.14 | 0.59% down | 26% up | ||
| 2 | PfizerPFE · Health Care | TRY 6.12T | TRY 8.18T | TRY 1,435.96 | 1.35% down | 14% up | ||
| 3 | Johnson & JohnsonJNJ · Health Care | TRY 5.93T | TRY 33.84T | TRY 14,056.96 | 1.36% down | 38% up | ||
| 4 | Eli LillyLLY · Health Care | TRY 4.33T | TRY 63.6T | TRY 71,396.94 | 1.13% down | 35% up | ||
| 5 | Merck & CoMRK · Health Care | TRY 4.25T | TRY 17.83T | TRY 7,231.24 | 0.75% down | 51% up | ||
| 6 | Bristol-Myers SquibbBMY · Health Care | TRY 3.61T | TRY 6.33T | TRY 3,094.35 | 2.51% down | 34% up | ||
| 7 | AstraZenecaAZN · Health Care | TRY 3.3T | TRY 14.26T | TRY 9,193.26 | 0.95% down | 2% up | ||
| 8 | NovartisNVS · Health Care | TRY 3.25T | TRY 15.16T | TRY 8,026.14 | 0.67% down | 25% up | ||
| 9 | SanofiSNY · Health Care | TRY 3.08T | TRY 5.76T | TRY 2,397.30 | 1.78% down | 4% down | ||
| 10 | GSKGSK · Health Care | TRY 3.02T | TRY 4.98T | TRY 2,483.55 | 2.32% down | 6% up | ||
| 11 | Novo NordiskNVO · Health Care | TRY 2.61T | TRY 9.05T | TRY 2,052.81 | 2.16% down | 17% down | ||
| 12 | Takeda PharmaceuticalTAK · Health Care | TRY 2.55T | TRY 3.49T | TRY 1,091.47 | 0.23% up | 54% up | ||
| 13 | Abbott LaboratoriesABT · Health Care | TRY 1.71T | TRY 9.15T | TRY 5,281.32 | 2.55% down | 17% down | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | TRY 1.66T | TRY 2.51T | TRY 2,149.65 | 0.12% up | 74% up | ||
| 15 | ViatrisVTRS · Health Care | TRY 1.13T | TRY 1.18T | TRY 1,031.45 | 1.40% down | 96% up | ||
| 16 | GrifolsGRFS · Health Care | TRY 677.6B | TRY 296.2B | TRY 435.28 | 1.15% down | 1% up | ||
| 17 | ZoetisZTS · Health Care | TRY 612.1B | TRY 1.71T | TRY 4,210.53 | 1.08% down | 29% down | ||
| 18 | Royalty PharmaRPRX · Health Care | TRY 499.6B | TRY 1.99T | TRY 3,464.05 | 0.23% up | 78% up | ||
| 19 | Regeneron PharmaceuticalsREGN · Health Care | TRY 469.2B | TRY 5T | TRY 48,307.12 | 0.56% up | 36% up | ||
| 20 | Jazz PharmaceuticalsJAZZ · Health Care | TRY 370.3B | TRY 779.3B | TRY 12,140.83 | 0.39% up | 37% up | ||
| 21 | GenmabGMAB · Health Care | TRY 354.4B | TRY 1.62T | TRY 2,620.74 | 0.76% up | 70% up | ||
| 22 | Vertex PharmaceuticalsVRTX · Health Care | TRY 351.9B | TRY 6.83T | TRY 26,943.77 | 0.67% down | 27% up | ||
| 23 | Elanco Animal HealthELAN · Health Care | TRY 343.5B | TRY 651.7B | TRY 1,303.81 | 2.12% down | 20% up | ||
| 24 | Alnylam PharmaceuticalsALNY · Health Care | TRY 210.7B | TRY 1.06T | TRY 7,893.48 | 2.02% down | 66% down | ||
| 25 | BeOne MedicinesONC · Health Care | TRY 193B | TRY 2.38T | TRY 20,843.84 | 0.48% up | 17% up | ||
| 26 | Amneal PharmaceuticalsAMRX · Health Care | TRY 185.2B | TRY 371.1B | TRY 1,065.24 | 0.52% down | 83% up | ||
| 27 | PTC TherapeuticsPTCT · Health Care | TRY 156.6B | TRY 254.3B | TRY 3,044.41 | 1.00% down | 20% down | ||
| 28 | Ionis PharmaceuticalsIONS · Health Care | TRY 153.1B | TRY 226.5B | TRY 1,359.80 | 3.75% down | 64% down | ||
| 29 | BridgeBio PharmaBBIO · Health Care | TRY 151.9B | TRY 754.6B | TRY 3,873.61 | 0.72% down | 17% up | ||
| 30 | Dr. Reddy's LaboratoriesRDY · Health Care | TRY 106.7B | TRY 621.9B | TRY 745.97 | 0.61% up | 5% up | ||
| 31 | CytokineticsCYTK · Health Care | TRY 105.1B | TRY 362.9B | TRY 2,605.10 | 2.86% down | 20% down | ||
| 32 | Ascendis PharmaASND · Health Care | TRY 82B | TRY 897.2B | TRY 13,678.17 | 0.20% down | 28% up | ||
| 33 | InsmedINSM · Health Care | TRY 76.9B | TRY 1.35T | TRY 6,146.33 | 0.83% down | 40% down | ||
| 34 | BioMarin PharmaceuticalBMRN · Health Care | TRY 76B | TRY 571.6B | TRY 2,951.10 | 0.90% up | 11% up | ||
| 35 | Arrowhead PharmaceuticalsARWR · Health Care | TRY 44.5B | TRY 306.5B | TRY 2,168.31 | 2.76% down | 10% up | ||
| 36 | United TherapeuticsUTHR · Health Care | TRY 39.5B | TRY 1.25T | TRY 29,460.60 | 0.64% down | 23% up | ||
| 37 | Legend BiotechLEGN · Health Care | TRY 36.9B | TRY 157.6B | TRY 812.55 | 0.75% up | 42% down | ||
| 38 | AlkermesALKS · Health Care | TRY 33.7B | TRY 385.2B | TRY 2,292.39 | 2.32% down | 58% up | ||
| 39 | Madrigal PharmaceuticalsMDGL · Health Care | TRY 33.1B | TRY 494.4B | TRY 21,284.16 | 0.46% down | 24% down | ||
| 40 | Axsome TherapeuticsAXSM · Health Care | TRY 30.3B | TRY 360.7B | TRY 6,856.99 | 0.77% down | 7% down | ||
| 41 | Ligand PharmaceuticalsLGND · Health Care | TRY 27.4B | TRY 296.4B | TRY 14,819.07 | 2.62% down | 43% up | ||
| 42 | Mirum PharmaceuticalsMIRM · Health Care | TRY 26.6B | TRY 302.8B | TRY 4,637.74 | 0.40% up | 31% up | ||
| 43 | Travere TherapeuticsTVTX · Health Care | TRY 24.7B | TRY 247.4B | TRY 2,577.36 | 2.82% up | 44% up | ||
| 44 | Roivant SciencesROIV · Health Care | TRY 21B | TRY 1.41T | TRY 1,952.44 | 0.26% up | 90% up | ||
| 45 | TG TherapeuticsTGTX · Health Care | TRY 20.9B | TRY 478.1B | TRY 3,162.94 | 0.08% down | 107% up | ||
| 46 | Cogent BiosciencesCOGT · Health Care | TRY 15.2B | TRY 244.4B | TRY 1,404.69 | 1.49% up | 20% down | ||
| 47 | Rhythm PharmaceuticalsRYTM · Health Care | TRY 10.6B | TRY 407.8B | TRY 5,881.53 | 8.49% up | 13% up | ||
| 48 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | TRY 9.9B | TRY 376.9B | TRY 4,797.12 | 0.93% up | 126% up | ||
| 49 | Corcept TherapeuticsCORT · Health Care | TRY 9.5B | TRY 386.8B | TRY 3,534.16 | 1.23% up | 8% down | ||
| 50 | ABIVAXABVX · Health Care | TRY 7.2B | TRY 362.5B | TRY 4,140.93 | 1.81% down | 27% down | ||
| 51 | Definium TherapeuticsDFTX · Health Care | TRY 5.4B | TRY 202.9B | TRY 1,481.86 | 2.59% down | 169% up | ||
| 52 | Summit TherapeuticsSMMT · Health Care | TRY 4.7B | TRY 430.4B | TRY 538.17 | 9.73% down | 36% down | ||
| 53 | ErascaERAS · Health Care | TRY 3.6B | TRY 245.9B | TRY 700.58 | 8.07% down | 403% up | ||
| 54 | Spyre TherapeuticsSYRE · Health Care | TRY 3.2B | TRY 449.4B | TRY 4,731.55 | 5.60% down | 286% up | ||
| 55 | Praxis Precision MedicinesPRAX · Health Care | TRY 3B | TRY 430.1B | TRY 15,386.49 | 1.68% down | 61% up | ||
| 56 | Protagonist TherapeuticsPTGX · Health Care | TRY 2.7B | TRY 410.4B | TRY 6,288.06 | 0.13% down | 46% up | ||
| 57 | Dianthus TherapeuticsDNTH · Health Care | TRY 1.9B | TRY 247B | TRY 4,387.06 | 2.87% down | 113% up | ||
| 58 | Edgewise TherapeuticsEWTX · Health Care | TRY 1.5B | TRY 232.1B | TRY 2,120.40 | 3.75% down | 88% up | ||
| 59 | Oruka TherapeuticsORKA · Health Care | TRY 841.7M | TRY 329.5B | TRY 4,858.15 | 2.94% down | 241% up | ||
| 60 | Belite BioBLTE · Health Care | TRY 507.9M | TRY 323.1B | TRY 7,955.02 | 2.98% down | 31% up | ||
| 61 | VeradermicsMANE · Health Care | TRY 461.8M | TRY 267.4B | TRY 6,336.98 | 1.88% down | 233% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total liabilities is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Where a company reports no total-liabilities line, it is worked out as assets less equity. Sums are converted from US dollars at today's exchange rate (1 USD = 50.4376 TRY).
Questions and answers
Which pharmaceuticals rank first by total liabilities?
AbbVie (TRY 6.92T), Pfizer (TRY 6.12T) and Johnson & Johnson (TRY 5.93T) are the top three of the 61 pharmaceuticals ranked by total liabilities as of 18 Nov 2026, 14:03 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by total liabilities.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by total liabilities have a combined market value of TRY 260.17T as of 18 Nov 2026, 14:03 UTC.
What does ranking by total liabilities measure?
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceuticals by total liabilities”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=total-liabilities
Underlying data: Yahoo Finance; SEC EDGAR.